Immune activation, inflammation and HIV DNA after 96 weeks of ATV/r monotherapy: a MODAt substudy

Antivir Ther. 2018;23(7):633-637. doi: 10.3851/IMP3234.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adult
  • Atazanavir Sulfate
  • DNA*
  • HIV
  • Heterocyclic Compounds, 3-Ring
  • Humans
  • Inflammation*
  • Oxazines
  • Piperazines
  • Pyridones

Substances

  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • Atazanavir Sulfate
  • DNA
  • dolutegravir